Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01780155 · ClinicalTrials.gov registry record

Genes Associated With Bronchopulmonary Dysplasia and Retinopathy of Prematurity

A clinical trial, sponsored by National Institute of Environmental Health Sciences (NIEHS).

Completed
Registry status
1,068
Enrollment target

NCT01780155: Completed study, sponsored by National Institute of Environmental Health Sciences (NIEHS).

NCT01780155 is a clinical trial that has completed, run by National Institute of Environmental Health Sciences (NIEHS). The registered enrollment target is 1,068 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01780155 has completed, sponsored by National Institute of Environmental Health Sciences (NIEHS).

COMPLETED
Registry status
1,068 participants
Enrollment target

Study Summary

Background: \- Some premature babies develop bronchopulmonary dysplasia (BPD) and retinopathy of prematurity (ROP). BPD and ROP are long-term chronic diseases of the lungs and eyes, respectively. BPD is associated with receiving mechanical ventilation to treat respiratory distress syndrome, and causes lung inflammation and scarring. ROP is caused by poor development of blood vessels in the eyes, and may lead to blindness. Because not all premature babies develop BPD or ROP, researchers want to study the genes that could be associated with these diseases. They will look at both premature infants and their parents to see if there is a genetic component to BPD and ROP. Objectives: \- To study genes that may be associated with BPD and ROP. Eligibility: * Premature babies born with a weight less than or equal to 1,250 grams. * Parents of the premature babies. Design: * Parents will answer questions about the mother s health and pregnancy. * Delivery and medical information will be collected during the baby s hospitalization for the first month after birth. * Parents will provide a saliva sample from the inside of the cheek. * A saliva sample will also be collected from the baby within 28 days of birth. If the baby needs tracheal aspiration (removal of fluid from the throat), tracheal fluid samples will also be collected. * Parents will have followup interviews about their child s health 6 months, 12 months, and yearly for up to 6 years after birth. * This is a genetic study only. Treatment will not be provided as part of this study.

Trial Details

FieldValue
Enrollment Target 1,068 participants
Start Date 2013-06-24
Est. Completion 2020-08-01

What the finished NCT01780155 record still lists

NCT01780155 is an observational study that tracks outcomes without assigning an intervention. Its 1,068 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT01780155 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01780155 about?

NCT01780155 is a clinical study titled "Genes Associated With Bronchopulmonary Dysplasia and Retinopathy of Prematurity". Background: \- Some premature babies develop bronchopulmonary dysplasia (BPD) and retinopathy of prematurity (ROP). BPD and ROP are long-term chronic diseases of the lungs and eyes, respectively. BPD is associated with receiving mechanical ventilation to treat respiratory distress syndrome, and cau...

What is the current status of trial NCT01780155?

This trial is currently completed. The enrollment target is 1,068 participants. The study started on 2013-06-24. Estimated completion is 2020-08-01.

Who is sponsoring clinical trial NCT01780155?

This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04165798 · 1,065 participants

    KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

  • NCT06751043 · 1,072 participants · NA

    Preoperative Fasting vs. Not Fasting in Critically Ill Patients

  • NCT06159673 · 1,074 participants · Phase 2

    ACP-204 in Adults With Alzheimer's Disease Psychosis

  • NCT06658808 · 1,075 participants · NA

    Efficacy-Implementation Study for PC CARES in Rural Alaska

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01780155, the US trial registry maintained by the National Library of Medicine. NCT01780155 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.